Phenome-genome association studies of pancreatic cancer: New targets for therapy and diagnosis

Cancer Genomics and Proteomics

Volumn 12, Issue 1, 2015, Pages 9-19

  Narayanan, Ramaswamy ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Biomarkers; Body fluids; Clinical variations; Dark matter proteome; Druggable targets; Expression quantitative loci; Gene ontology; Genome Wide Association Studies; Leukemia and lymphoma; Malignant melanoma; Neuroblastoma; Open reading frames; Pancreatic cancer; Phenome genome association

Indexed keywords

CHEMOKINE; G PROTEIN COUPLED RECEPTOR; HORMONE RECEPTOR; MEMBRANE PROTEIN; MESSENGER RNA; MITOCHONDRIAL PROTEIN; PROTEOME; RIBOSOME PROTEIN; TUMOR MARKER; UNTRANSLATED RNA;

ARTICLE; ASCITES; CANCER THERAPY; CLINICAL ARTICLE; COPY NUMBER VARIATION; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN GENOME; OPEN READING FRAME; PANCREAS CANCER; PANCREAS JUICE; PROTEIN EXPRESSION; PROTEIN SECRETION; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; FEMALE; GENETICS; MALE; PANCREATIC NEOPLASMS; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM;

FEMALE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84920530882     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Warsame R and Grothey A: Treatment options for advanced pancreatic cancer: a review. Expert review of anticancer therapy 12(10):1327-1336, 2012.
2. Paulson AS, Tran Cao HS, Tempero MA and Lowy AM: Therapeutic advances in pancreatic cancer. Gastroenterology 144(6):1316-1326, 2013.
3. Valsecchi ME, Diaz-Canton E, De La Vega M and Littman SJ: Recent treatment advances and novel therapies in pancreas cancer: a review. Journal of gastrointestinal cancer 45(2):190-201, 2014.
4. Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK and Hruban RH: Recent progress in pancreatic cancer. CA: A Cancer Journal for Clinicians 63:318-348, 2013.
5. Zhang Y, De S, Garner JR, Smith K, Wang SA and Becker KG: Systematic analysis, comparison, and integration of disease based human genetic association data and mouse genetic phenotypic information. BMC medical genomics 3:1, 2010.
6. Ramos EM, D. Hoffman, H. A. Junkins, D. Maglott, L. Phan, S. T. Sherry, M. Feolo and L. A. Hindorff: Phenotype-Genotype Integrator (PheGenI): Phenotype-Genotype Integrator (PheGenI): synthesizing genome-wide association study (GWAS) data with existing genomic resources. Eur J Hum Genet 22(1):144-147, 2014.
7. Kim MS, Pinto SM, Getnet D, Nirujogi RS, Manda SS, Chaerkady R, Madugundu AK, Kelkar DS, Isserlin R, Jain S, Thomas JK, Muthusamy B, Leal-Rojas P, Kumar P, Sahasrabuddhe NA, Balakrishnan L, Advani J, George B, Renuse S, Selvan LD, Patil AH, Nanjappa V, Radhakrishnan A, Prasad S, Subbannayya T, Raju R, Kumar M, Sreenivasamurthy SK, Marimuthu A, Sathe GJ, Chavan S, Datta KK, Subbannayya Y, Sahu A, Yelamanchi SD, Jayaram S, Rajagopalan P, Sharma J, Murthy KR, Syed N, Goel R, Khan AA, Ahmad S, Dey G, Mudgal K, Chatterjee A, Huang TC, Zhong J, Wu X, Shaw PG, Freed D, Zahari MS, Mukherjee KK, Shankar S, Mahadevan A, Lam H, Mitchell CJ, Shankar SK, Satishchandra P, Schroeder JT, Sirdeshmukh R, Maitra A, Leach SD, Drake CG, Halushka MK, Prasad TS, Hruban RH, Kerr CL, Bader GD, Iacobuzio-Donahue CA, Gowda H and Pandey A: A draft map of the human proteome. Nature 509(7502):575-578, 2014.
8. Wilhelm M, Schlegl J, Hahne H, Moghaddas Gholami A, Lieberenz M, Savitski MM, Ziegler E, Butzmann L, Gessulat S, Marx H, Mathieson T, Lemeer S, Schnatbaum K, Reimer U, Wenschuh H, Mollenhauer M, Slotta-Huspenina J, Boese JH, Bantscheff M, Gerstmair A, Faerber F and Kuster B: Massspectrometrybased draft of the human proteome. Nature 509(7502):582-587, 2014.
9. Martin L and Chang HY: Uncovering the role of genomic "dark matter" in human disease. The Journal of clinical investigation 122(5):1589-1595, 2012.
10. Babcock JJ and Li M: Deorphanizing the human transmembrane genome: A landscape of uncharacterized membrane proteins. Acta pharmacologica Sinica 2013.
11. Blaxter M: Genetics. Revealing the dark matter of the genome. Science 330(6012):1758-1759, 2010.
12. Delgado AP BP, Hamid S and Narayanan R: Mining the dark matter of the cancer proteome for novel biomarkers. Current Cancer Therapy Reviews 9(4):265-277, 2013.
13. Delgado A, Brandao P, Chapado M, Hamid S and Narayanan R: Open reading frames associated with cancer in the dark matter of the human genome. Cancer genomics & proteomics 11(4):201-213, 2014a.
14. Delgado A, Hamid S, Brandao P and Narayanan R: A novel transmembrane glycoprotein cancer biomarker present in the x chromosome. Cancer genomics & proteomics 11(2):81-92, 2014b.
15. Delgado A, Brandao P and Narayanan R: Diabetes Associated Genes from the Dark Matter of the Human Proteome. MOJ Proteomics Bioinform 1(4):00020, 2014c.
16. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, Teague JW, Campbell PJ, Stratton MR and Futrel PA: COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic acids research 39 (Database issue):D945-950, 2011.
17. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C and Schultz N: The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer discovery 2(5):401-404, 2012.
18. Bulusu KC, Tym JE, Coker EA, Schierz AC and Al-Lazikani B: canSAR: updated cancer research and drug discovery knowledgebase. Nucleic acids research 42 (Database issue):D1040-7, 2014.
19. Huang DW, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protocols 4(1):44-57, 2008.
20. Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, Nativ N, Bahir I, Doniger T, Krug H, Sirota-Madi A, Olender T, Golan Y, Stelzer G, Harel A and Lancet D: GeneCards Version 3: the human gene integrator. Database 2010;2010.
21. Consortium GT: The Genotype-Tissue Expression (GTEx) project. Nature genetics 45(6):580-585, 2013.
22. MacDonald JR, Ziman R, Yuen RK, Feuk L and Scherer SW: The Database of Genomic Variants: a curated collection of structural variation in the human genome. Nucleic acids research 42 (Database issue):D986-992, 2014.
23. Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM and Maglott DR: ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic acids research 42 (Database issue):D980-985, 2014.
24. Rhodes DR, S. Kalyana-Sundaram, V. Mahavisno, R. Varambally, J. Yu, B. B. Briggs, T. R. Barrette, M. J. Anstet, C. Kincead-Beal, P. Kulkarni, S. Varambally, D. Ghosh and Chinnaiyan AM: Oncomine 3.0: genes, pathways, and networks in a collection of 18, 000 cancer gene expression profiles. Neoplasia 2:166-80, 2007.
25. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S, Wernerus H, Bjorling L and Ponten F: Towards a knowledgebased Human Protein Atlas. Nature biotechnology 28(12):1248-1250, 2010.
26. Kolker E, Higdon R, Haynes W, Welch D, Broomall W, Lancet D, Stanberry L and Kolker N: MOPED: Model Organism Protein Expression Database. Nucleic acids research 40 (Database issue):D1093-1099, 2012.
27. Keshava Prasad TS, Goel R, Kandasamy K, Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R, Shafreen B, Venugopal A, Balakrishnan L, Marimuthu A, Banerjee S, Somanathan DS, Sebastian A, Rani S, Ray S, Harrys Kishore CJ, Kanth S, Ahmed M, Kashyap MK, Mohmood R, Ramachandra YL, Krishna V, Rahiman BA, Mohan S, Ranganathan P, Ramabadran S, Chaerkady R and Pande A: Human Protein Reference Database - 2009 update. Nucleic acids research 37 (Database issue):D767-72, 2009.
28. Marlaire S, Van Schaftingen E and Veiga-da-Cunha M: C7orf10 encodes succinate-hydroxymethylglutarate CoA-transferase, the enzyme that converts glutarate to glutaryl-CoA. Journal of inherited metabolic disease 37(1):13-19, 2014.
29. Punta M, Coggill PC, Eberhardt RY, Mistry J, Tate J, Boursnell C, Pang N, Forslund K, Ceric G, Clements J, Heger A, Holm L, Sonnhammer EL, Eddy SR, Bateman A and Finn RD: The Pfam protein families database. Nucleic acids research 40 (Database issue):D290-301, 2012.
30. Hunter S, Jones P, Mitchell A, Apweiler R, Attwood TK, Bateman A, Bernard T, Binns D, Bork P, Burge S, De Castro E, Coggill P, Corbett M, Das U, Daugherty L, Duquenne L, Finn RD, Fraser M, Gough J, Haft D, Hulo N, Kahn D, Kelly E, Letunic I, Lonsdale D, Lopez R, Madera M, Maslen J, McAnulla C, McDowall J, McMenamin C, Mi H, Mutowo-Muellenet P, Mulder N, Natale D, Orengo C, Pesseat S, Punta M, Quinn AF, Rivoire C, Sangrador-Vegas A, Selengut JD, Sigrist CJ, Scheremetjew M, Tate J, Thimmajanarthanan M, Thomas PD, Wu CH, Yeats C and Yong SY: InterPro in 2011: new developments in the family and domain prediction database. Nucleic acids research 40 (Database issue):D306-12, 2012.
31. Petersen TN, Brunak S, Von Heijne G and Nielsen H: SignalP 4.0: discriminating signal peptides from transmembrane regions. Nature methods 8(10):785-786, 2011.
32. Letunic I, Doerks T and Bork P: SMART: recent updates, new developments and status in 2015. Nucleic acids research 2014.
33. Sigrist CJ, E. De Castro, L. Cerutti, B. A. Cuche, N. Hulo, A. Bridge, L. Bougueleret and Xenarios I: New and continuing developments at PROSITE. Nucleic acids research 41 (Database issue):D344-347, 2013.
34. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM: ONCOMINE: a cancer microarray database and integrated datamining platform. Neoplasia 6(1):1-6, 2004.
35. Zhang B, Wang J, Wang X, Zhu J, Liu Q, Shi Z, Chambers MC, Zimmerman LJ, Shaddox KF, Kim S, Davies SR, Wang S, Wang P, Kinsinger CR, Rivers RC, Rodriguez H, Townsend RR, Ellis MJ, Carr SA, Tabb DL, Coffey RJ, Slebos RJ, Liebler DC, N. C. the, C. National Cancer Institute Clinical Proteomics Tumor Analysis, N. C. National Cancer Institute Clinical Proteomics Tumor Analysis Consortium and N. C. National Cancer Institute Clinical Proteomics Tumor Analysis Consortium: Proteogenomic characterization of human colon and rectal cancer. Nature 513:382-393, 2014.
36. Vogel C and Marcotte EM: Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nature reviews Genetics 13(4):227-232, 201.
37. Greenbaum D, Colangelo C, Williams K and Gerstein M: Comparing protein abundance and mRNA expression levels on a genomic scale. Genome biology 4(9):117, 2003.
38. Narayanan R and Van De Ven WJ: Transcriptome and Proteome Analysis: A Perspective on Correlation. MOJ Proteomics Bioinform 1(5):00027, 2014.
39. Sherman, EA, K. A. Strauss, S. Tortorelli, Bennett MJ, Knerr I, Morton DH and Puffenberger EG EG: Genetic mapping of glutaric aciduria, type 3, to chromosome 7 and identification of mutations in c7orf10. American journal of human genetics 83(5):604-609, 2008.
40. Kusama T, Mukai M, Iwasaki T, Tatsuta M, Matsumoto Y, Akedo H, Inoue M and Nakamura H: 3-hydroxy-3-methylglutarylcoenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis. Gastroenterology 122(2):308-317, 2002.
41. Tom Tang Y, P. Emtage, W. D. Funk, T. Hu, M. Arterburn, E. E. Park and Rupp F: TAFA: a novel secreted family with conserved cysteine residues and restricted expression in the brain. Genomics 83(4):727-734, 2004.
42. Wu C, Miao X, Huang L, Che X, Jiang G, Yu D, Yang X, Cao G, Hu Z, Zhou Y, Zuo C, Wang C, Zhang X, Zhou Y, Yu X, Dai W, Li Z, Shen H, Liu L, Chen Y, Zhang S, Wang X, Zhai K, Chang J, Liu Y, Sun M, Cao W, Gao J, Ma Y, Zheng X, Cheung ST, Jia Y, Xu J, Tan W, Zhao P, Wu T, Wang C and Lin D: Genomewide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nature genetics 44(1):62-66, 2012.
43. Wormann SM, Diakopoulos KN, Lesina M and Algul H: The immune network in pancreatic cancer development and progression. Oncogene 33(23):2956-2967, 2014.